GUBRA
Gubra ApS
Application Filed: 2018-09-20
Trademark Application Details
NON-FINAL ACTION COUNTED - NOT MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79246634 |
| Registration Number | 5958193 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Law Office Assigned | N40 |
| Employee Name | GOODWIN, KATRINA JOYE |
Timeline
| 2018-09-20 | Application Filed |
| 2019-01-05 | Location: TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED |
| 2019-01-05 | Status: Live/Pending |
| 2019-01-06 | Transaction Date |
| 2019-10-29 | Published for Opposition |
| 2020-01-14 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Gubra ApS |
| Address | Hørsholm Kongevej 11 B Hørsholm DK |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DK |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 35 |
| U.S. Codes: | 100,101,102 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Medical services; veterinary services; hygienic and beauty care for human being or animals |
| GS0051 | Pharmaceutical and veterinary preparations for the prevention of metabolic, inflammatory, fibrotic, central nervous system, cardiovascular, renal, hepatic, gastrointestinal, cancer, immune-system disorders; sanitary preparations for medical purposes; neuro-pharmaceutical preparations in the nature of pharmaceutical preparations for the treatment of metabolic, inflammatory, fibrotic, central nervous system, cardiovascular, renal, hepatic, gastrointestinal, cancer, immune-system disorders; preparations for treating neurological disorders; chemicals preparations for medical purposes, namely, for metabolic, inflammatory, fibrotic, central nervous system, cardiovascular, renal, hepatic, gastrointestinal, cancer, immune-system disorders; chemicals used in the treatment of neurological disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2018-11-29 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-11-30 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2018-12-04 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2019-01-02 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2019-01-05 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-01-06 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2019-01-17 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-01-17 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2019-02-02 | 9 RFNT P: |
| CORRECTION CREATED FOR IB | 2019-04-23 | 10 CRCR E:E-Mail |
| CORRECTION SENT TO IB | 2019-04-23 | 11 CRSN M: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-07-17 | 12 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2019-07-22 | 13 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-07-23 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-07-23 | 15 TEME I:Incoming Correspondence |
| CORRECTION TRANSACTION RECEIVED FROM IB | 2019-08-09 | 16 CRCV M: |
| USPTO CORRECTION PROCESSED BY IB | 2019-08-09 | 17 RINX P: |
| EXAMINERS AMENDMENT -WRITTEN | 2019-08-16 | 18 CNEA R:Renewal |
| EXAMINER'S AMENDMENT ENTERED | 2019-08-16 | 19 XAEC I:Incoming Correspondence |
| EXAMINERS AMENDMENT MAILED | 2019-08-19 | 20 CNEA O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2019-08-20 | 21 CNRT R:Renewal |
| NON-FINAL ACTION MAILED | 2019-08-21 | 22 CNRT O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-09-05 | 23 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-09-09 | 24 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-09-09 | 25 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-09-23 | 26 CNSA O:Outgoing Correspondence |
| REFUSAL PROCESSED BY IB | 2019-10-05 | 27 RFNT P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-10-09 | 28 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2019-10-09 | 29 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-10-09 | 30 OPNS P: |
| CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 2019-10-18 | 31 CORN I:Incoming Correspondence |
| NOTIFICATION PROCESSED BY IB | 2019-10-25 | 32 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2019-10-29 | 33 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-10-29 | 34 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-01-14 | 35 R.PR A:Allowance for Publication |
| LIMITATION OF GOODS RECEIVED FROM IB | 2020-02-14 | 36 LIMG M: |
| LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 2020-02-28 | 37 LIMN I:Incoming Correspondence |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-04-14 | 38 FICR P: |
| FINAL DISPOSITION PROCESSED | 2020-04-29 | 39 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2020-04-29 | 40 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-05-15 | 41 FINO P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2020-09-18 | 42 NREP P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-08-13 | 43 NREP P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 